Navigation Links
DrugRisk Updates with Latest Case Numbers Since Januvia Lawsuits Sent to MDL Court
Date:9/24/2013

New York, NY (PRWEB) September 24, 2013

The diabetes drug safety center at DrugRisk.com is announcing new information on the site for patients taking the medications Januvia or Janumet. A federal multidistrict litigation court recently created to handle lawsuits alleging the drugs caused pancreatic cancer has issued the latest update on case volumes*.

DrugRisk is a resource center created to improve patient safety by giving those taking popular prescription drugs the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are popular oral diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for pharmaceutical company Merck**.

However, DrugRisk has added studies warning of a risk of Januvia cancer. In 2011, researchers from UCLA discovered subjects given Januvia had an increased risk of developing pancreatic cancer and thyroid cancer***. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).

Now, the latest records from the court show 60 people have already filed a Januvia lawsuit or similar action relating to Byetta, Janumet or Victoza*.

Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases,

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. DrugRisk Update: Byetta Lawsuits Headed to Special Federal Court
2. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
3. DrugRisk Update: Latest Court Order Moves Mirena Lawsuits Forward
4. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
5. DrugRisk Update: Court Issues Latest Decision in Pradaxa Bleeding Litigation
6. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
7. DrugRisk Update: Panel To Decide Fate of Januvia Lawsuits Next Week
8. DrugRisk Announces Latest Ruling By Judicial Panel on NuvaRing Lawsuits
9. DrugRisk Announces Drop in Yaz Lawsuits As Bayer Commits $1.5 Billion to Settlements
10. DrugRisks Announces Yaz Center With Latest Updates on Blood Clot Warnings and Settlements
11. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... 03, 2014 CS3 Technology, a Sage ... and support of Sage 100 ERP, Sage 500 ERP, ... America Million Dollar Club achiever for surpassing a million ... recognizes CS3 Technology and all Million Dollar Club achievers ... of Sage, its business partners and the mutual customers ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Health ... increases patient safety, decreases medical errors, and strengthens ... , To mark the important role health information ... IHS and others across the U.S. have joined ... Week , September 16-20, 2014. With the NHIT ...
(Date:9/3/2014)... Immersion Active (ImmersionActive.com ), the digital ... in the 2014 Content Marketing Awards presented by the ... leading awards program for people who create content for ... strategic purpose. , Immersion Active’s winning entry was ... Home Instead Senior Care®. This series addresses people who ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Independent ... use of appropriate evidence-based health care along the ... benefit from the expertise of accredited independent review ... health care system. , As a core function, ... often settle questions of medical necessity. Yet backed ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 "What can you ... Thus begins "Margaret and Hillary," Book Eight in the ... Rhyse and published by Wyston Books, Inc . These ... wealthy friends in the richest town in America. , In ... as she helps to investigate a student’s murder plot. Her ...
Breaking Medicine News(10 mins):Health News:CS3 Technology Named a Sage Million Dollar Club Achiever for 2013-2014 2Health News:Innovative Healthcare Solutions (IHS) Celebrates National Health IT Week September, 15-19, 2014 2Health News:Immersion Active Wins Silver for Email Strategy in 2014 Content Marketing Awards 2Health News:Independent Review Expands Its Scope: Case Studies in Context 2Health News:Independent Review Expands Its Scope: Case Studies in Context 3Health News:Town Locked Down After Bombing and Murders in "Margaret and Hillary" - New Book Eight in the Margaret of Greenwich(R) Young Adult Series by R. L. Rhyse 2
... 1994, the team of Tchernev and Petrova from Alexandrovska ... cirrhosis caused by chronic Hepatitis C virus (HCV). They ... vascular lesions on the lower limbs, acute pain in ... labor-impairing fatigue. They were also intrigued by the presence ...
... for treatment of patients with chronic hepatitis B ... leads to the emergence of lamivudine-resistant hepatitis B ... with HBV. Sensitive methods for early detection of ... in treating patients with HBV infection. , To ...
... what you eat free of bacteria , , WEDNESDAY, Jan. 16 ... bear much of the burden for keeping the nation,s food ... at home. , Here are some common-sense precautions: , ... as eggs, are well-cooked before you eat them. Use a ...
... appears to be a distinctive sexual orientation and not ... "on their way" to lesbianism, according to new research ... study of 79 non-heterosexual women over 10 years found ... attraction to both sexes. In addition, the research appears ...
... Benefit All Babies, WHITE PLAINS, N.Y., Jan. 15 ... expectant moms --,initially overjoyed -- can be left feeling ... ever for moms to get the information they need., ... baby health,in the most convenient way possible," said Dr. ...
... American Academy of,Ophthalmology expresses its sadness at the ... inhibitors sparked major advances in the,treatment of eye ... angiogenesis, or blood vessel development., "Dr. Folkman,s ... all of,medicine," said H. Dunbar Hoskins, Jr., MD, ...
Cached Medicine News:Health News:Attention: Extra-hepatic manifestation of hepatitis C virus infection 2Health News:What is the more suitable for early detection of low abundant lamivudine-resistant mutants? 2Health News:Bisexuality not a transitional phase among women, according to new research 2Health News:March of Dimes Offers New Resources for Pregnancy and Baby Health 2Health News:March of Dimes Offers New Resources for Pregnancy and Baby Health 3Health News:American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher 2
(Date:9/3/2014)... ,    ... ~   Kiadis Pharma B.V. ... biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, ... , MD PhD, as its Chief Medical Officer. ... at Ceronco Biosciences. Prior to that he was VP ...
(Date:9/2/2014)... 2014 Reportbuyer.com has added a new ... Technologies for Molecular Imaging Devices ... The objectives of this study are to ... used for diagnostic purposes, present global market measurements ... market segments as well as forecast market and ...
(Date:9/2/2014)... -- Numotion is pleased to announce the appointment of Mark ... Mark is a 30-year retired veteran of GE where ... and was a GE Company Officer since 1999 and a ... running business units within GE Healthcare, with the most recent ... "We are delighted to welcome Mark to our Board," ...
Breaking Medicine Technology:Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Global Markets and Technologies for Molecular Imaging Devices 2Global Markets and Technologies for Molecular Imaging Devices 3Global Markets and Technologies for Molecular Imaging Devices 4Global Markets and Technologies for Molecular Imaging Devices 5Global Markets and Technologies for Molecular Imaging Devices 6Global Markets and Technologies for Molecular Imaging Devices 7Global Markets and Technologies for Molecular Imaging Devices 8Global Markets and Technologies for Molecular Imaging Devices 9Global Markets and Technologies for Molecular Imaging Devices 10Global Markets and Technologies for Molecular Imaging Devices 11Global Markets and Technologies for Molecular Imaging Devices 12Global Markets and Technologies for Molecular Imaging Devices 13Global Markets and Technologies for Molecular Imaging Devices 14Global Markets and Technologies for Molecular Imaging Devices 15Global Markets and Technologies for Molecular Imaging Devices 16Global Markets and Technologies for Molecular Imaging Devices 17Global Markets and Technologies for Molecular Imaging Devices 18Global Markets and Technologies for Molecular Imaging Devices 19Global Markets and Technologies for Molecular Imaging Devices 20Global Markets and Technologies for Molecular Imaging Devices 21Global Markets and Technologies for Molecular Imaging Devices 22Global Markets and Technologies for Molecular Imaging Devices 23Global Markets and Technologies for Molecular Imaging Devices 24Global Markets and Technologies for Molecular Imaging Devices 25
... Tenn., Nov. 18, 2011 MedSolutions , ... services, today announced the launch of its Implantable ... evidence-based guidelines to ensure the clinical appropriateness of ... With the cost of each ICD/CRT-D ...
... Md., Nov. 18, 2011 The U.S. Food and ... ) to treat patients with acute lymphoblastic leukemia (ALL), ... coli derived asparaginase and pegaspargase chemotherapy drugs used ... ) Acute lymphoblastic leukemia is a ...
Cached Medicine Technology:MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 3FDA Approves Erwinaze to Treat a Form of Leukemia 2FDA Approves Erwinaze to Treat a Form of Leukemia 3
... Insulin-like growth factor II (IGF-II) is a ... the liver and is postulated to have mitogenic ... actions of IGF-II are mediated by binding to ... to the Type II IGF receptor, a monomeric ...
... (PAPP-A) is a large placenta-derived glycoprotein ... concentrations by placental trophoblast cells, and ... in increasing concentrations throughout gestation until ... to pregnancy since measurable levels have ...
... proteohormone with a molecular weight of 16 kDa. ... and produced by adipocytes [1,2]. Leptin is thought ... body weight [1-3]. In the human, leptin levels ... women [4]. A relationship between serum leptin levels ...
... known as Anti-Mullerian Inhibiting Substance (AMH), is ... kDa monomers linked by disulfide bridges (1). ... (TGF-?) superfamily which includes TGF-? and the ... members of this superfamily are dimeric glycoproteins, ...
Medicine Products: